-
1
-
-
10744228443
-
Improved detection of focal liver lesions at MR imaging: Multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings
-
; European EOB Study Group.
-
Huppertz A, Balzer T, Blakeborough A, et al. European EOB Study Group. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 2004; 230: 266-275.
-
(2004)
Radiology
, vol.230
, pp. 266-275
-
-
Huppertz, A.1
Balzer, T.2
Blakeborough, A.3
-
2
-
-
25144495562
-
Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study
-
Bluemke DA, Sahani D, Amendola M, et al. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study. Radiology 2005; 237: 89-98.
-
(2005)
Radiology
, vol.237
, pp. 89-98
-
-
Bluemke, D.A.1
Sahani, D.2
Amendola, M.3
-
3
-
-
12344296444
-
Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: Correlation with histopathologic findings and spiral CT-initial observations
-
Huppertz A, Haraida S, Kraus A, et al. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT-initial observations. Radiology 2005; 234: 468-478.
-
(2005)
Radiology
, vol.234
, pp. 468-478
-
-
Huppertz, A.1
Haraida, S.2
Kraus, A.3
-
4
-
-
68049120628
-
Detection and characterization of focal hepatic tumors: A comparison of T2-weighted MR images before and after the administration of gadoxectic acid
-
Kim YK, Kwak HS, Kim CS, Han YM,. Detection and characterization of focal hepatic tumors: a comparison of T2-weighted MR images before and after the administration of gadoxectic acid. J Magn Reson Imaging 2009; 30: 437-443.
-
(2009)
J Magn Reson Imaging
, vol.30
, pp. 437-443
-
-
Kim, Y.K.1
Kwak, H.S.2
Kim, C.S.3
Han, Y.M.4
-
5
-
-
70350456265
-
Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: Which biological markers of the liver function affect the enhancement?
-
Motosugi U, Ichikawa T, Sou H, et al. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging 2009; 30: 1042-1046.
-
(2009)
J Magn Reson Imaging
, vol.30
, pp. 1042-1046
-
-
Motosugi, U.1
Ichikawa, T.2
Sou, H.3
-
6
-
-
70349669251
-
Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI)
-
Motosugi U, Ichikawa T, Sou H, et al. Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI). J Magn Reson Imaging 2009; 30: 849-854.
-
(2009)
J Magn Reson Imaging
, vol.30
, pp. 849-854
-
-
Motosugi, U.1
Ichikawa, T.2
Sou, H.3
-
7
-
-
75749105062
-
Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: A comparison of gadoxetic acid and gadobenate dimeglumine
-
Filippone A, Blakeborough A, Breuer J, et al. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine. J Magn Reson Imaging 2010; 31: 356-364.
-
(2010)
J Magn Reson Imaging
, vol.31
, pp. 356-364
-
-
Filippone, A.1
Blakeborough, A.2
Breuer, J.3
-
8
-
-
0026533551
-
Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system
-
Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U,. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992; 183: 59-64.
-
(1992)
Radiology
, vol.183
, pp. 59-64
-
-
Schuhmann-Giampieri, G.1
Schmitt-Willich, H.2
Press, W.R.3
Negishi, C.4
Weinmann, H.J.5
Speck, U.6
-
9
-
-
0036895706
-
Gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid interaction with clinical drugs in rats
-
Kato N, Yokawa T, Tamura A, Heshiki A, Ebert W, Weinmann HJ,. Gadolinium-ethoxybenzyl-diethylenetriamine-pentaacetic acid interaction with clinical drugs in rats. Invest Radiol 2002; 37: 680-684.
-
(2002)
Invest Radiol
, vol.37
, pp. 680-684
-
-
Kato, N.1
Yokawa, T.2
Tamura, A.3
Heshiki, A.4
Ebert, W.5
Weinmann, H.J.6
-
10
-
-
34247390725
-
The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3
-
Seithel A, Eberl S, Singer K, et al. The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3. Drug Metab Dispos 2007; 35: 779-786.
-
(2007)
Drug Metab Dispos
, vol.35
, pp. 779-786
-
-
Seithel, A.1
Eberl, S.2
Singer, K.3
-
11
-
-
0034815177
-
Abc protein transport of MRI contrast agents in canalicular rat liver plasma vesicles and yeast vacuoles
-
Pascolo L, Petrovic S, Cupelli F, et al. Abc protein transport of MRI contrast agents in canalicular rat liver plasma vesicles and yeast vacuoles. Biochem Biophys Res Commun 2001; 282: 60-66.
-
(2001)
Biochem Biophys Res Commun
, vol.282
, pp. 60-66
-
-
Pascolo, L.1
Petrovic, S.2
Cupelli, F.3
-
12
-
-
66949157207
-
Gadoxate-enhanced T 1-weighted MR cholangiography: Comparison of 1.5 T and 3.0 T
-
Koelblinger C, Schima W, Weber M, et al. Gadoxate-enhanced T 1-weighted MR cholangiography: comparison of 1.5 T and 3.0 T. Rofo 2009; 181: 587-592.
-
(2009)
Rofo
, vol.181
, pp. 587-592
-
-
Koelblinger, C.1
Schima, W.2
Weber, M.3
-
13
-
-
0029003150
-
Phase i clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: Safety, pharmacokinetics, and MR imaging
-
Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging. Radiology 1995; 195: 785-792.
-
(1995)
Radiology
, vol.195
, pp. 785-792
-
-
Hamm, B.1
Staks, T.2
Muhler, A.3
-
14
-
-
27544442176
-
Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths
-
Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ,. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40: 715-724.
-
(2005)
Invest Radiol
, vol.40
, pp. 715-724
-
-
Rohrer, M.1
Bauer, H.2
Mintorovitch, J.3
Requardt, M.4
Weinmann, H.J.5
-
15
-
-
79551555208
-
-
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) 1999 Available at:. Assessed October 31
-
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER). Guidance for industry: population pharmacokinetics; 1999. Available at:. Assessed October 31, 2010.
-
(2010)
Guidance for Industry: Population Pharmacokinetics
-
-
-
16
-
-
0021702968
-
An exact confidence interval for untransformed data for the ratio of two formulation means
-
Locke CS,. An exact confidence interval for untransformed data for the ratio of two formulation means. J Pharmacokinet Biopharm 1984; 12: 649-655.
-
(1984)
J Pharmacokinet Biopharm
, vol.12
, pp. 649-655
-
-
Locke, C.S.1
-
17
-
-
1242272736
-
Organic anion transporting polypeptides of the OATP/ SLC21 family: Phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties
-
Hagenbuch B, Meier PJ,. Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch 2004; 447: 653-665.
-
(2004)
Pflugers Arch
, vol.447
, pp. 653-665
-
-
Hagenbuch, B.1
Meier, P.J.2
-
18
-
-
0037427972
-
The superfamily of organic anion transporting polypeptides
-
Hagenbuch B, Meier PJ,. The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta 2003; 1609: 1-18.
-
(2003)
Biochim Biophys Acta
, vol.1609
, pp. 1-18
-
-
Hagenbuch, B.1
Meier, P.J.2
-
19
-
-
33645110538
-
Pharmacogenomics of human OATP transporters
-
König J, Seithel A, Gradhand U, Fromm MF,. Pharmacogenomics of human OATP transporters. Naunyn Schmiedebergs Arch Pharmacol 2006; 372: 432-443.
-
(2006)
Naunyn Schmiedebergs Arch Pharmacol
, vol.372
, pp. 432-443
-
-
König, J.1
Seithel, A.2
Gradhand, U.3
Fromm, M.F.4
-
20
-
-
13844314148
-
Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs
-
Shitara Y, Sato H, Sugiyama Y,. Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs. Annu Rev Pharmacol Toxicol 2005; 45: 689-723.
-
(2005)
Annu Rev Pharmacol Toxicol
, vol.45
, pp. 689-723
-
-
Shitara, Y.1
Sato, H.2
Sugiyama, Y.3
-
21
-
-
0037310871
-
Inhibition of trans- porter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A
-
Shitara Y, Itoh T, Sato H, Li AP, Sugiyama Y,. Inhibition of trans- porter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A. J Pharmacol Exp Ther 2003; 304: 610-616.
-
(2003)
J Pharmacol Exp Ther
, vol.304
, pp. 610-616
-
-
Shitara, Y.1
Itoh, T.2
Sato, H.3
Li, A.P.4
Sugiyama, Y.5
-
22
-
-
0036293982
-
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver
-
Vavricka SR, van Montfoort J, Ha HR, Meier PJ, Fattinger K,. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Hepatology 2002; 36: 164-172.
-
(2002)
Hepatology
, vol.36
, pp. 164-172
-
-
Vavricka, S.R.1
Van Montfoort, J.2
Ha, H.R.3
Meier, P.J.4
Fattinger, K.5
-
23
-
-
0033045409
-
Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1
-
van Montfoort JE, Stieger B, Meijer DK, Weinmann HJ, Meier PJ, Fattinger KE,. Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther 1999; 290: 153-157.
-
(1999)
J Pharmacol Exp Ther
, vol.290
, pp. 153-157
-
-
Van Montfoort, J.E.1
Stieger, B.2
Meijer, D.K.3
Weinmann, H.J.4
Meier, P.J.5
Fattinger, K.E.6
-
24
-
-
68149084824
-
Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma
-
Narita M, Hatano E, Arizono S, et al. Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma. J Gastroenterol 2009; 44: 793-798.
-
(2009)
J Gastroenterol
, vol.44
, pp. 793-798
-
-
Narita, M.1
Hatano, E.2
Arizono, S.3
-
25
-
-
16544374913
-
The organic anion transporter (OATP) family
-
Mikkaichi T, Suzuki T, Tanemoto M, Ito S, Abe T,. The organic anion transporter (OATP) family. Drug Metab Pharmacokinet 2004; 19: 171-179.
-
(2004)
Drug Metab Pharmacokinet
, vol.19
, pp. 171-179
-
-
Mikkaichi, T.1
Suzuki, T.2
Tanemoto, M.3
Ito, S.4
Abe, T.5
-
26
-
-
70350048926
-
Impact of OATP transporters on pharmacokinetics
-
Kalliokoski A, Niemi M,. Impact of OATP transporters on pharmacokinetics. Br J Pharmacol 2009; 158: 693-705.
-
(2009)
Br J Pharmacol
, vol.158
, pp. 693-705
-
-
Kalliokoski, A.1
Niemi, M.2
-
27
-
-
0040368659
-
Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1
-
Abe T, Kakyo M, Tokui T, et al. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem 1999; 274: 17159-17163.
-
(1999)
J Biol Chem
, vol.274
, pp. 17159-17163
-
-
Abe, T.1
Kakyo, M.2
Tokui, T.3
-
28
-
-
0034725617
-
Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide
-
Konig J, Cui Y, Nies AT, Keppler D,. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem 2000; 275: 23161-23168.
-
(2000)
J Biol Chem
, vol.275
, pp. 23161-23168
-
-
Konig, J.1
Cui, Y.2
Nies, A.T.3
Keppler, D.4
-
29
-
-
33747866680
-
Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination
-
Smith NF, Figg WD, Sparreboom A,. Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination. Expert Opin Drug Metab Toxicol 2005; 1: 429-445.
-
(2005)
Expert Opin Drug Metab Toxicol
, vol.1
, pp. 429-445
-
-
Smith, N.F.1
Figg, W.D.2
Sparreboom, A.3
-
30
-
-
0018154631
-
Pharmacokinetic study of rifampicin in biliary surgery
-
Kiss IJ, Farago E, Kiss B, Varhelyi I,. Pharmacokinetic study of rifampicin in biliary surgery. Int J Clin Pharmacol Biopharm 1978; 16: 105-109.
-
(1978)
Int J Clin Pharmacol Biopharm
, vol.16
, pp. 105-109
-
-
Kiss, I.J.1
Farago, E.2
Kiss, B.3
Varhelyi, I.4
-
31
-
-
67649362277
-
In vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions
-
Kindla J, Fromm MF, Konig J,. In vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions. Expert Opin Drug Metab Toxicol 2009; 5: 489-500.
-
(2009)
Expert Opin Drug Metab Toxicol
, vol.5
, pp. 489-500
-
-
Kindla, J.1
Fromm, M.F.2
Konig, J.3
-
32
-
-
67651211678
-
Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005
-
Karlowsky JA, Lagace-Wiens PR, Low DE, Zhanel GG,. Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005. Int J Antimicrob Agents 2009; 34: 375-379.
-
(2009)
Int J Antimicrob Agents
, vol.34
, pp. 375-379
-
-
Karlowsky, J.A.1
Lagace-Wiens, P.R.2
Low, D.E.3
Zhanel, G.G.4
-
33
-
-
66749164674
-
Ten years of antibiotic consumption in ambulatory care: Trends in prescribing practice and antibiotic resistance in Austria
-
Metz-Gercek S, Maieron A, Strauss R, Wieninger P, Apfalter P, Mittermayer H,. Ten years of antibiotic consumption in ambulatory care: trends in prescribing practice and antibiotic resistance in Austria. BMC Infect Dis 2009; 9: 61.
-
(2009)
BMC Infect Dis
, vol.9
, pp. 61
-
-
Metz-Gercek, S.1
Maieron, A.2
Strauss, R.3
Wieninger, P.4
Apfalter, P.5
Mittermayer, H.6
-
34
-
-
33846513465
-
Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): Trends, regional differences and seasonal fluctuations
-
ESAC Project Group.
-
Elseviers MM, Ferech M, Vander Stichele RH, Goossens H,; ESAC Project Group. Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf 2007; 16: 115-123.
-
(2007)
Pharmacoepidemiol Drug Saf
, vol.16
, pp. 115-123
-
-
Elseviers, M.M.1
Ferech, M.2
Vander Stichele, R.H.3
Goossens, H.4
-
35
-
-
0023515562
-
Erythromycin lactobionate: Pharmacokinetics and uterine tissue levels
-
Segui A, Milon D, Cormier M, Lepesant G,. Erythromycin lactobionate: pharmacokinetics and uterine tissue levels. Eur J Drug Metab Pharmacokinet 1987; 12: 153-160.
-
(1987)
Eur J Drug Metab Pharmacokinet
, vol.12
, pp. 153-160
-
-
Segui, A.1
Milon, D.2
Cormier, M.3
Lepesant, G.4
-
36
-
-
0020397015
-
Dose-related pharmacokinetics after oral administration of a new formulation of erythromycin base
-
Josefsson K, Bergan T, Magni L,. Dose-related pharmacokinetics after oral administration of a new formulation of erythromycin base. Br J Clin Pharmacol 1982; 13: 685-691.
-
(1982)
Br J Clin Pharmacol
, vol.13
, pp. 685-691
-
-
Josefsson, K.1
Bergan, T.2
Magni, L.3
-
37
-
-
33745243715
-
Drug-drug interaction between pitavastatin and various drugs via OATP1B1
-
Hirano M, Maeda K, Shitara Y, Sugiyama Y,. Drug-drug interaction between pitavastatin and various drugs via OATP1B1. Drug Metab Dispos 2006; 34: 1229-1236.
-
(2006)
Drug Metab Dispos
, vol.34
, pp. 1229-1236
-
-
Hirano, M.1
Maeda, K.2
Shitara, Y.3
Sugiyama, Y.4
|